Izigaba Zokwelapha

Ukwelashwa Okuvelele

I-Diffuse large B-cell lymphoma (DLBCL)-04

Ukwelashwa kwe-CAR-T kwe-Myasthenia Gravis (MG)

Ukwelashwa Ngegciwane Le-Oncolytic: Ukwelashwa Komdlavuza Okuthuthukisiwe

Umfana olwa ne-acute lymphoblastic leukemia

Ukunqoba i-Diffuse Large B-Cell Lymphoma nge-Bioocus Dual CAR-T Therapy

Ukulwa ne-Hepatocellular Carcinoma nge-Bioocus GPC3 CAR-T Therapy

$Impendulo Ephawulekayo ku-Refractory Multiple Myeloma Ngemva Kokwelashwa Kwamaseli e-CAR-T$

Impendulo Ephawulekayo ku-Refractory Multiple Myeloma Ngemva Kokwelashwa Kwamaseli e-CAR-T

Ukunqoba kukaMadhavan: Ukunqoba i-Brain Glioma nge-Bioocus B7H3 CAR-T Therapy

Umfana omncane oqinile waseRussia ulwa ne-neuroblastoma

Indoda ezimisele evela eNdiya ilwa nomdlavuza wesisu

0102030405

I-CAR-T ye-Carcinoma ye-Hepatocellular

Uma wena noma othandekayo wakho nitholakale ninesifo i-hepatocellular carcinoma (HCC), uhlobo oluvame kakhulu lomdlavuza wesibindi oyinhloko, kungenzeka ukuthi nifuna izinketho ezithuthukisiwe zokuphatha lesi sifo esiyinselele. Ukwelashwa kwendabuko njengokuhlinzwa, i-chemotherapy, noma ukwelashwa okuqondiwe kungasebenza kwabanye, kodwa ezimweni ezithuthukile, ukwelashwa kwamasosha omzimba okusha njengokwelashwa kwamaseli e-CAR-T kunikeza indlela eyenzelwe wena ngokunika amandla amasosha omzimba wakho ukulwa namaseli omdlavuza ngempumelelo enkulu. Kwa-Bioocus, sihlola ukwelashwa kwe-CAR-T njengengxenye yezinhlelo zokunakekelwa eziphelele, sithatha ucwaningo oluqhubekayo ukuze sinikeze ithemba ngenkathi sigxile ekuphepheni kanye nekhwalithi yokuphila.

Xhumana nathi

Isingeniso

Imiphumela Yezokwelapha Nedatha

Ukwelashwa Okuhambisanayo

Ukuthatha Isinyathelo Esilandelayo

Iseli le-CAR-T

I-CAR-T (iseli le-T le-Chimeric Antigen Receptor) ukwelashwa kuyindlela entsha yokwelapha ngezifo ezithathelwanayo eshintsha amaseli akho e-T ukuze aqaphele futhi abhubhise kangcono amaseli omdlavuza. Ku-HCC, lokhu kwelashwa kuhlose amaprotheni athile kumaseli esimila, okungenzeka anikeze okwengeziwe okunye okuqondile noma isiphelelisi ukwelashwa okujwayelekile.

Kuhilela ukuqoqa nokwakha amangqamuzana akho omzimba elebhu ngaphambi kokuwavuselela, kuhloswe ukufeza izimpendulo ezihlala isikhathi eside nge imiphumela emibi embalwa yesistimu.

Ama-Targets ekwelashweni kwe-CAR-T kwe-Hepatocellular Carcinoma

I-Glypican-3 (GPC3) iyinhloso eyinhloko yokwelashwa kwe-CAR-T ku-HCC ngenxa yokubonakaliswa kwayo okuphezulu kumaseli omdlavuza wesibindi kanye nokuba khona okuncane ezicutshini zabantu abadala abanempilo.

I-GPC3 iyiprotheni engaphezulu kweseli ekhuthaza ukukhula kwesimila ngokuthuthukisa izindlela zokudlulisela izimpawu ezifana ne-Wnt, ezikhuthaza ukwanda komdlavuza. Ngokuqondisa amaseli e-CAR-T ukuthi abophe i-GPC3, ukwelashwa kugxila ekuhlaselweni kwamasosha omzimba kumaseli anomdlavuza, okusindisa ukusebenza kwesibindi okuvamile ngangokunokwenzeka. Leli cebo eliqondiwe libaluleke kakhulu ezigulini ezine-HCC ethuthukisiwe ezingazange zisabele ekwelashweni kwangaphambilini.

Indlela Ukwelashwa Kwe-CAR-T Okusebenza Ngayo: Indlela Yokusebenza

Inqubo yokwelashwa kwe-CAR-T yenzelwe ukuqinisa nokuqinisa izivikelo zemvelo zomzimba wakho:

Iqoqo: Isampula yamaseli akho e-T itholakala ngenqubo elula efana nokudonsa igazi.
Ubunjiniyela: Elabhorethri, la maseli e-T aguqulwa ngokwezakhi zofuzo ukuze aveze i-chimeric antigen receptor (CAR) eqaphela ngqo i-GPC3 kumaseli e-HCC.
Ukuvuselelwa Nokwandiswa: Amaseli aguquliwe akhuliswa ngobuningi futhi asebenze ukuze abe abalwi bomdlavuza abanamandla.
UkufakwaAmaseli e-CAR-T aphinde afakwe egazini lakho, lapho efuna khona futhi abopha khona amaseli esimila aveza i-GPC3.
Ukuhlasela: Lapho ebopha, amaseli e-CAR-T akhipha izimpawu zokubhubhisa amaseli omdlavuza, okungase kuholele ekunciphiseni isimila kanye nokuqapha okuqhubekayo kokuzivikela komzimba.

Le ndlela ihlose ukunikeza impendulo eqhubekayo, yize ukuqapha okuseduze kubalulekile ukulawula noma yimiphi imiphumela ehlobene nokuzivikela komzimba.

umdwebo wesimiso se-CAR-T.jpg

Ukwelashwa kwe-CAR-T okuqondiswe ku-GPC3 kwe-carcinoma yesibindi ikhombisa ukusebenza kahle okukhulu ezivivinyweni zemitholampilo. Esifundweni sethu seziguli ezingu-30 ezine-HCC ethuthukisiwe ye-GPC3 ezahluleka ukwelashwa kwangaphambilini, izinga lokuphendula ngobuqotho lalingu-56.6%, kufaka phakathi Izimpendulo ezingaphelele ezingama-53.3%. Izinga lokulawula izifo lifinyelelwe 86.7%, ngesilinganiso esimaphakathi ukusinda okungenalo inqubekela phambili kwezinyanga ezingu-13 futhi ukusinda okuphelele kwezinyanga ezingu-14.6. Ukwelashwa kuphephile, ikakhulukazi nge-cytokine release syndrome emnene kanye nemiphumela emibi elawulekayo. Siyaqhubeka nokuba yizingqalabutho zalezi zindlela zokwelapha ukuze sithuthukise imiphumela yeziguli ezinomdlavuza wesibindi.

Ukwelashwa Ngemisebe Yomzimba Oku-Stereotactic (SBRT)

Le ndlela enembile yokukhipha imisebe ihlose izimila ezincane zesibindi ngemithamo ephezulu ngezikhathi ezimbalwa, kunciphisa usayizi wesimila futhi okungenzeka kuthuthukise ukungena kwamaseli e-CAR-T ngenkathi kunciphisa umonakalo ezicutshini zesibindi ezizungezile.

SBRT图.png

Ukususwa Okungenelelayo

Izinqubo ezingangenisi kakhulu njenge-radiofrequency noma i-microwave ablation zibhubhisa izicubu zesimila ngokushisa, okudala indawo lapho amaseli e-CAR-T angahlasela khona amaseli omdlavuza asele ngempumelelo.

Isithombe sokufakelwa.png

I-Transarterial Chemoembolization (TACE)

Ngokunikeza i-chemotherapy ngqo esimila ngemithambo yesibindi nokuvimba ukutholakala kwegazi, i-TACE inciphisa izimila futhi ingase ihambisane ne-CAR-T ngokwenza buthaka ukuzivikela komdlavuza nokuthuthukisa impendulo yomzimba.

Ukuhlinzwa

Ezigulini ezifanelekile, ukususwa kwesibindi okuyingxenye kungasusa isifo esikhulu, okuvumela i-CAR-T ukuthi igxile ezinsaleleni ezincane kakhulu.

Lezi zinhlanganisela zihlose ukuthuthukisa imiphumela ngenkathi zibeka phambili induduzo yakho kanye nempilo yesibindi.

imibuzo ejwayelekile ukubuzwa

Ingabe ukwelashwa kwe-CAR-T kufaneleka kubo bonke iziguli ze-HCC? Ngokuvamile kubhekwa kulabo abanezimila ezine-GPC3-positive asebeqhubekele phambili ekwelashweni okujwayelekile. Ukuhlolwa okuphelele, okuhlanganisa nokuhlolwa kwe-biomarker, kunquma ukufaneleka.
Yimiphi imiphumela emibi engingayithola? Ezivamile zifaka phakathi izimpawu ezifana nomkhuhlane ezivela ku-CRS, ukukhathala, noma izinguquko zesikhashana zokusebenza kwesibindi, eziqashwa futhi zelashwe ngokushesha.
Inqubo yokwelashwa ithatha isikhathi esingakanani? Kusukela ekuqoqweni kwamaseli kuya ekufakweni, kuvame ukuthatha amasonto ambalwa, kulandelwe ukulandelwa okuvamile ukuhlola impendulo.

Uma uhlola Ukwelashwa kwe-CAR-T ngoba umdlavuza wesibindi, ithimba lethu kwa-Bioocus likulungele ukuxoxa ngokuthi lingahlanganiswa kanjani nohlelo lwakho lokunakekelwa. Xhumana ukuze uthole iseluleko ukuze ubuyekeze izinketho zakho ngesiqondiso esisekelwe ebufakazini—uhambo lwakho lokuphatha okungcono luqala ngokukhetha okunolwazi.

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.